MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Targets Growing Need for Non-Invasive Intoxication Detection

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

• MindBio Therapeutics is developing AI-powered voice analysis technology designed to detect drug and alcohol impairment from short speech samples.
• The platform analyzes more than 140 acoustic markers and has been trained on a dataset exceeding 50 million data points.
• Mining operations in South America represent the company’s initial commercial focus, where workforce safety and high-volume screening requirements create operational challenges.
• Potential applications extend beyond mining into aviation, construction, law enforcement, call centers, transportation, and mental health settings.
• The global alcohol and drug testing devices market is projected to grow from approximately $2.5 billion in 2025 to $4.2 billion by 2033.
• MindBio’s approach seeks to provide a faster, less invasive alternative to traditional breath, saliva, urine and laboratory-based testing methods.

Workplace impairment testing remains an essential component of risk management across many industries, but the methods used today have changed relatively little over the past several decades. Employers continue to rely heavily on breathalyzers, saliva tests, urine screening and laboratory analysis to identify alcohol and drug impairment. While effective, these methods can be expensive, time-consuming and difficult to scale across large workforces. That challenge is becoming increasingly relevant as regulators and employers place greater emphasis on workplace safety, compliance and operational efficiency.

Against this backdrop, MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF), a biotechnology company, is developing a technology platform that takes a different approach. The company has spent several years conducting drug and alcohol research while building artificial intelligence and machine-learning models designed to estimate intoxication levels through speech analysis. Rather than requiring biological samples, the platform analyzes voice recordings captured through standard microphones.

According to the company, its system evaluates more than 140 acoustic markers and has been trained using more than 50 million data points collected through extensive research programs. The objective is straightforward: identify measurable changes in speech associated with alcohol or drug impairment and generate an assessment in real time.

The commercial opportunity surrounding that capability may be substantial. The global alcohol and drug testing devices market is expected to expand from approximately $2.5 billion in 2025 to $4.2 billion by 2033 as employers adopt new safety technologies and regulatory requirements continue to evolve (https://ibn.fm/88jXn).

The need extends well beyond regulatory compliance. In industries such as mining, aviation, transportation and construction, impairment screening is often mandated because employees operate heavy equipment, work in hazardous environments or perform safety-sensitive tasks where mistakes can carry significant consequences.

Large organizations may process hundreds or thousands of workers each day, creating logistical challenges when traditional testing methods are used. MindBio believes artificial intelligence can help address that issue. The company is developing Edge AI kiosk systems designed to collect short voice samples from workers entering a facility. Within seconds, the system could potentially identify indicators of impairment and flag individuals requiring further evaluation.

This process would replace traditional screening models that are time consuming, unhygienic and expensive on a per test basis. This new category changing testing solution may function as a rapid screening layer that helps employers allocate resources more efficiently while reducing operational bottlenecks.

Mining has emerged as the company’s initial target market. Many mining operations, particularly in South America, involve remote sites, rotating workforces and physically demanding environments where safety monitoring is critical and drug and alcohol consumption is a major problem. Traditional testing programs can become expensive and administratively burdensome when deployed across large numbers of employees.

MindBio has indicated that field testing of its kiosk technology is expected during 2026, providing an important opportunity to evaluate performance in real-world industrial settings.

The potential market extends well beyond mining. The company has previously highlighted aviation and construction as logical applications because both sectors already operate within regulatory frameworks that require impairment management and workforce monitoring. In aviation, rapid screening tools could potentially assist operators managing large employee populations across multiple facilities. Construction companies face similar challenges, particularly on large infrastructure projects where contractors, subcontractors and temporary workers may need to be screened efficiently.

Another area attracting attention is call-center operations. While call centers are not typically associated with physical safety risks, employers increasingly monitor employee performance, wellness and productivity. Because communication occurs almost entirely through speech, voice analytics may provide additional insights regarding impairment, fatigue or behavioral changes.

Mental health and healthcare settings present another potential use case. Voice analysis has increasingly been studied as a tool for identifying changes in emotional state, stress levels and cognitive function. While MindBio’s primary focus remains intoxication detection, the broader field of speech analytics continues to attract interest from researchers exploring non-invasive health monitoring technologies.

Law enforcement may also represent a future opportunity. Officers frequently encounter situations where immediate assessment of impairment would be valuable, yet laboratory testing may not be readily available. A rapid voice-based screening tool could potentially serve as an additional assessment mechanism.

What differentiates MindBio from many technology companies entering workplace safety markets is the foundation of its research. The company’s machine-learning models are derived from years of drug and alcohol studies, creating datasets specifically designed to examine the relationship between speech patterns and impairment. Management believes that proprietary data may become a significant competitive advantage as artificial intelligence applications expand across healthcare and enterprise markets.

For more information, visit the company’s website at www.MindBioTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to MBQIF are available in the company’s newsroom at https://ibn.fm/MBQIF

About TechMediaWire

TechMediaWire (“TMW”) is a specialized communications platform with a focus on pioneering public and private companies driving the future of technology. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, TMW brings its clients unparalleled recognition and brand awareness. TMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Austin, Texas
www.TechMediaWire.com
512.354.7000 Office
Editor@TechMediaWire.com

TechMediaWire is powered by IBN